Related Experiment Video
Updated: Mar 22, 2026
Evaluation of Biomarkers in Glioma by Immunohistochemistry on Paraffin-Embedded 3D Glioma Neurosphere Cultures
Published on: January 9, 2019
Molecular Pathology and Biomarkers
Abstract:
The field of salivary gland tumor biology is quite broad, given the numerous subtypes of both benign and malignant tumors originating from the major and minor salivary glands. Knowledge about the molecular pathology of these lesions is still limited, and there are few clinically useful diagnostic and prognostic biomarkers. However, recent discoveries of certain key genomic alterations, such as chromosome translocations, copy number alterations, and mutations, provide new insights into the molecular pathogenesis of these lesions and may help to better define them. It is also hoped that this new knowledge can help to guide therapy, but this translation has been somewhat slow to develop, perhaps due to the rarity of these tumors and the lack of large, randomized studies. However, because of the limitations inherent in what surgery and radiation can provide, there is an urgent need for understanding of the mechanisms of carcinogenesis in these tumors individually, so that chemotherapy and/or targeted therapy can be rationally selected.
Insights
Discoveries in salivary gland tumor genomics offer new insights into pathogenesis. Understanding these molecular alterations is crucial for developing targeted therapies for rare salivary gland cancers.
Area of Science:
- Oncology
- Molecular Pathology
- Genomics
Background:
- Salivary gland tumors encompass diverse benign and malignant subtypes.
- Current knowledge of molecular pathology and biomarkers for these tumors is limited.
- Existing treatments like surgery and radiation have inherent limitations.
Purpose of the Study:
- To explore recent genomic discoveries in salivary gland tumors.
- To understand the molecular pathogenesis of these lesions.
- To identify potential biomarkers for diagnosis and prognosis.
Main Methods:
- Review of recent discoveries in key genomic alterations.
- Analysis of chromosome translocations, copy number alterations, and mutations.
- Examination of insights into molecular pathogenesis.
Main Results:
- Genomic alterations provide new insights into salivary gland tumor pathogenesis.
- These discoveries may aid in better classification of salivary gland lesions.
- The translation of this knowledge into clinical therapy is progressing slowly.
Conclusions:
- Urgent need exists to understand individual tumor carcinogenesis mechanisms.
- Targeted therapies require a rational selection based on molecular understanding.
- Further research is needed to bridge the gap between genomic discoveries and clinical application.
Related Concept Videos
02:34DNA Microarrays
01:29Modern Molecular Taxonomy
01:29Pharmacogenomics: Identification of New Drug Targets
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...